INDICATION(S):
Pigs
For the treatment and metaphylaxis of porcine proliferative enteropathy (ileitis) caused by Lawsonia intracellularis, and associated enteric pathogens (Escherichia coli) susceptible to lincomycin and spectinomycin.
The presence of the disease in the group must be established before the product is used.
Chickens
For the treatment and metaphylaxis of chronic respiratory disease (CRD) caused by Mycoplasma gallisepticum and Escherichia coli susceptible to lincomycin and spectinomycin, and associated with a low mortality rate.
The presence of the disease in the flock must be established before the product is used.
COMPOSITION:
- 33.3 g/150 g Lincomycin (as Lincomycin hydrochloride monohydrate)
- 66,7 g/150 g Spexctinomycin (as Spectinomycin sulfate tetrahidrate)
PRESENTATION:
150 g, 500 g, 1.5 kg and 2.5 kg
TARGET SPECIES:
- POULTRY
